PRTA Message Board Post 9196716 | Prothena Corporation plc
home / stock / prta / prta message board
(investorshub)
Posted on: Nov/04/2020 21:15:30
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159303985
BREAKING NEWS: $PRTA Prothena Reports Third Quarter 2020
News, Short Squeeze, Breakout and More Instantly...
Prothena Corporation plc Company Name:
PRTA Stock Symbol:
Market:
-
Prothena to receive $80 million from Bristol Myers Squibb for exclusive global license to PRX019, a potential treatment of neurodegenerative diseases with an undisclosed target Prothena will initiate a Phase 1 clinical trial for PRX019 in 2024 Prothena Corporation plc (NASDAQ:PRTA),...
-
2024-05-23 11:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
Net cash used in operating and investing activities was $73.2 million in the first quarter of 2024; quarter-end cash and restricted cash position was $548.7 million Advanced potential best-in-class Alzheimer’s disease portfolio: initial data supportive of ongoing Phase 1 clinical trial...